7 results
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
activity for systemic antifungal ... agents Antifungals ... fluconazole; ISA ... #antibiogram #management ... #pharmacology #
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
B for initial management ... - Virtually never ... #Pharmacology #Antibiotics ... #Flutycosine #Antifungal
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Note: Systemic antifungals ... candida #mucosal #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... depending on their level ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... hypokalemia, phlebitis, fever ... #valleyfever #management ... #treatment #antifungals ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... hypokalemia, phlebitis, fever ... chest/back pain #Antifungal ... Coccidioidomycosis #pharmacology ... #management #treatment
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... lesion(s), the level ... Cytomegalovirus #CMV #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology